Evaluation

Gender disparities in opioid treatment progress in methadone versus counselling

Citation
Guerrero, E., Amaro, H., Kong, Y. et al. Gender disparities in opioid treatment progress in methadone versus counseling. Subst Abuse Treat Prev Policy 16, 52 (2021). https://doi.org/10.1186/s13011-021-00389-4
Publication Date

The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies.

High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder

Citation
Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128
Publication Date

In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to investigate the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.

Trends in use of e-cigarette device types and heated tobacco products from 2016 to 2020 in England

Citation
Tattan-Birch, H., Brown, J., Shahab, L. et al. Trends in use of e-cigarette device types and heated tobacco products from 2016 to 2020 in England. Sci Rep 11, 13203 (2021). https://doi.org/10.1038/s41598-021-92617-x
Publication Date

During the past decade, heated aerosolized nicotine delivery systems (HANDS) —mainly e-cigarettes—have surpassed nicotine replacement therapy as the most utilized aids for stopping smoking in England.

Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centres with SBIRT services

Citation
Watson, D.P., Staton, M.D., Dennis, M.L. et al. Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centers with SBIRT services. Subst Abuse Treat Prev Policy 16, 58 (2021). https://doi.org/10.1186/s13011-021-00381-y
Publication Date

Brief treatment (BT) or regular outpatient alcohol use or substance use disorder (SUD) treatment is a key element of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model. It can be an effective, short-term, and low-cost treatment option for many people who misuse alcohol and drugs. Nevertheless, inconsistent BT implementation often costs similar to regular outpatient care.

Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study

Citation
Khouja JN, Wootton RE, Taylor AE, Davey Smith G, Munafò MR (2021) Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study. PLoS Med 18(3): e1003555.
Publication Date

Background:

Tobacco smoking and e-cigarette use are strongly associated, but it is currently unclear whether this association is causal, or due to shared factors that influence both behaviours such as a shared genetic liability. The aim of this study was to investigate whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes.

 

UNODC’s Strategic Vision for Africa 2030

Published by
UNODC

UNODC’s Strategic Vision for Africa 2030 outlines our mission to provide more safety to Africa’s people, government and institutions from drugs, crime, corruption, terrorism and illicit financial flows.

The UNODC Vision 2030 seeks to strengthen crime prevention, enhance justice, address organized crime, ensure a balanced response to drugs, improve the rule of law and bolster resilience.

Webinar: Presentation of the Pandemic Impact Report at Treatment Centers in Latin America

Publication Date

ISSUP Argentina invites you to participate in a webinar presenting the main results of the multicenter study carried out by the national chapters of ISSUP (Argentina, Brazil, Chile, Ecuador and Mexico).
The webinar will take place on Thursday, December 3, 2020 at 11:00 a.m. (Argentine time).